Plain-English translation of NCT06793085 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying how inflammation in the body relates to PCOS and insulin resistance — a condition where the body doesn't respond normally to insulin. By measuring specific inflammatory markers in blood samples from women with PCOS, women with PCOS but without insulin problems, and women without PCOS, the study aims to find better ways to identify who is at risk for serious health complications.
PCOS affects many women and can lead to heart disease and other serious health problems, especially when combined with insulin resistance. Current tests don't do a good job of predicting who will develop complications. This study hopes to find new, more precise markers in the blood that can identify these risks earlier and help doctors prevent problems before they start.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will have blood drawn so researchers can measure specific inflammation markers using laboratory tests. Your blood sample will be analyzed to measure levels of proteins related to inflammation and your metabolic health. This is an observational study, meaning researchers are observing and measuring — not giving you any medication or treatment.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
Poland
Jagiellonian University
Enrollment target
~100 participants
Started
January 2025
Primary completion
June 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 45 Years
Sex
Female only
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Iwona Gawron, Ph.D., M.D.
Jagiellonian University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.